Additionally, RA-associated treatments with specific drugs, such as sDMARDS (methotrexate) and certain BDMARDs (rituximab and TNF-α inhibitors), carry a risk of exacerbating PAH (41). The gene discussed is TNF; the disease is pulmonary arterial hypertension.